Regentis Biomaterials Ltd. (RGNT)
NYSEAMERICAN: RGNT · Real-Time Price · USD
3.360
+0.010 (0.30%)
Mar 6, 2026, 4:00 PM EST - Market closed
Regentis Biomaterials Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Selling, General & Admin | 6.64 | 0.71 | 1.13 | 0.44 | 0.33 | |
| Research & Development | 0.33 | -1.64 | 0.81 | 0.97 | 0.34 | |
| Operating Expenses | 6.97 | -0.93 | 1.93 | 1.41 | 0.67 | |
| Operating Income | -6.97 | 0.93 | -1.93 | -1.41 | -0.67 | |
| Interest Expense | -0.08 | -0.01 | - | - | - | |
| Currency Exchange Gain (Loss) | 0.07 | 0.1 | -0.07 | 0.26 | -0.02 | |
| Other Non Operating Income (Expenses) | -6.67 | 3.78 | -2.13 | -0.3 | -4.46 | |
| Pretax Income | -13.65 | 4.8 | -4.13 | -1.45 | -5.14 | |
| Net Income | -13.65 | 4.8 | -4.13 | -1.45 | -5.14 | |
| Preferred Dividends & Other Adjustments | 0.04 | 4.52 | 0.05 | 0.05 | 0.05 | |
| Net Income to Common | -13.69 | 0.28 | -4.18 | -1.5 | -5.19 | |
| Shares Outstanding (Basic) | 1 | 0 | 0 | 0 | 0 | |
| Shares Outstanding (Diluted) | 1 | 0 | 0 | 0 | 0 | |
| Shares Change (YoY) | 249.41% | -6.52% | 6.97% | - | - | |
| EPS (Basic) | -24.16 | 1.72 | -24.09 | -9.23 | -32.00 | |
| EPS (Diluted) | -24.16 | 1.72 | -24.09 | -9.23 | -32.00 | |
| EBIT | -6.97 | 0.93 | -1.93 | -1.41 | -0.67 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.